Main Menu
Menu

Lamar Smith

Publish Date
Op-Eds
People are fed up, and Trump needs affordability win. Here’s his chance
The Washington Examiner
News
Senate Finance Committee Hears from ITC Nominees
IPWatchdog
Resources
Letters
C4IP Letter to Senate Finance Committee RE: Nomination of Peter-Anthony Pappas to the U.S. International Trade Commission
BlogFact Checks
Fact Check: Setting the Record Straight on PTAB Reform

The U.S. Patent and Trademark Office is considering reforms to address longstanding concerns about abuse of the Patent Trial and Appeal Board...

News
Senate Finance Committee to Hold Nomination Hearing on Pappas’ USITC Appointment
IPWatchdog
Press Releases
Council for Innovation Promotion Applauds Senate Judiciary Committee Advancement of the NO FAKES Act

WASHINGTON (June 18, 2026) — Today, the Senate Judiciary Committee voted to advance the bipartisan Nurture Originals, Foster Art, and Keep Entertainment...

BlogOp-Eds
Intellectual property supports the U.S. economy. It should be respected abroad.

In a recent Washington Post opinion piece, C4IP Co-Chair and former USPTO Director David Kappos and former Deputy U.S. Trade Representative Jeffrey...

The Washington Post
Press Releases
Council for Innovation Promotion Urges Senate Judiciary Committee To Advance NO FAKES Act

WASHINGTON (June 16, 2026) — On June 18, the Senate Judiciary Committee will vote on whether to advance the bipartisan Nurture Originals,...

Resources
Letters
C4IP Letter to Senate HELP Committee RE: Consideration of Medication Affordability and Patent Integrity Act
Blog
Inventor Spotlight: Robert Goddard

C4IP is recognizing Robert Goddard (1882-1945), the “Father of American Rocketry,” whose numerous patented inventions enabled modern spaceflight. Goddard was born amid...

News
C4IP Opposes Prohibiting Adversarial Patents Act, Releases Technology Ecosystems Report
IPWatchdog
News
Prohibiting Adversarial Patents Act Would Limit Patent Rights of National Security-Designated Entities
IPWatchdog
News:

News:

As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’,

05/30/2024
News:

News:

Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers,

05/29/2024
News:

News:

Ex-USPTO Directors Want Vidal To Withdraw Disclaimer Plans,

05/28/2024
News:

News:

Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking,

05/28/2024
Blog:

Blog, Fact Checks:

Fact Check: Price Controls Would Not Make Diabetes Treatments More Accessible,

05/24/2024
News:

News:

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents,

05/23/2024
News:

News:

Group chaired by former USPTO directors questions office’s AI guidance over ‘human contribution’,

05/21/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: May 21, 2024 Hearing on Drug Prices,

05/20/2024
News:

News:

Industry Reacts to USPTO Guidance on Using AI to Innovate,

05/20/2024
Resources:

Resources:

C4IP Letter to Senate Commerce, Science, & Transportation Committee RE: The Invent Here, Make Here Act of 2023,

05/15/2024
News:

News:

USPTO Guidance On AI And Patents Draws Worry And Praise,

05/14/2024
Resources:

Resources:

C4IP Comments RE: Inventorship Guidance for AI-Assisted Inventions (PTO-P-2023-0043),

05/13/2024
Scroll to Top